A Multiple Myeloma Trial in Patients With Bone Metastases

PHASE4CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Multiple Myeloma
Interventions
DRUG

zoledronic acid

4 mg zoledronic acid in 250 mL of calcium-free solution (i.e., 0.9% sodium chloride or 5% glucose) administered intravenously.

Trial Locations (68)

10021

New York Presbyterian Hospital, New York

11706

Hematology Oncology of Western Suffolk, Bay Shore

13210

Syracuse Hematology/Oncology PC, Syracuse

19104

University of Pennsylvania, Philadelphia, Philadelphia

19106

Pennsylvania Oncology Associates, Philadelphia

19611

Berks Oncology and Hematology Associates, West Reading

20735

Oncology Hematology Associates, PA, Clinton

20817

Center for Cancer and Blood Disorders, Bethesda

21044

Maryland Oncology-Hematology PA, Columbia

24153

Oncology Hematology Associates of Southwest VA, Salem

29403

Charleston Hematology Oncology, Charleston

30084

Georgia Cancer Specialists, Tucker

30901

Augusta Oncology Associates, Augusta

32174

MetCare Oncology, Ormond Beach

32501

Hematology Oncology Associates PA, Pensacola

32955

Hem/Onc Associates of Central Brevard, Rockledge

33021

South Florida Oncology Hematology, Hollywood

33133

Miami Cancer Care, Miami

33901

Florida Cancer Specialists, Fort Meyers

34652

Pasco Hernado Oncology, New Port Richey

34741

Osceola Cancer Center, Kissimmee

35801

Hematology Oncology Specialists, Huntsville

37920

Baptist Regional Cancer Center, Knoxville

45409

Dayton Oncology & Hematology, PA, Kettering

47150

Cancer Care Center, New Albany

48075

Providence Cancer Center, Clinical Trials Dept, Southfield

48144

Hematology Oncology Associates of Ohio & Michigan, Lambertville

54915

Fox Valley Hematology Oncology SC, Appleton

63141

The Center for Cancer Care and Research, St Louis

64131

Kansas City Cancer Center, Kansas City

64507

St. Joseph Oncology, Inc., Saint Joseph

67502

Hutchinson Clinic, PA, Hutchinson

68114

Nebraska Methodist Hospital, Omaha

70115

Hematology and Oncology Specialists, New Orleans

72205

Myeloma Institute For Research Therapy, Little Rock

University of Arkansas, Little Rock

75230

Center for Oncology Research & Treatment, PA, Dallas

79410

Joe Arrington Cancer Research and Treatment Center, Lubbock

80631

Greeley Medical Center, Greeley

84403

Utah Hematology Oncology, Ogden

85304

Palo Verde Hematology Oncology, Glendale

85710

US Oncology, Tucson

87505

New Mexico Cancer Care Associates, Santa Fe

89109

Comprehensive Cancer Centers of Nevada, Las Vegas

89128

Nevada Cancer Center, Las Vegas

90069

Oncotherapeutics, West Hollywood

90813

Pacific Shores Medical Group, Long Beach

91345

North Valley H/O, Mission Hills

92037

Dr. Robert P. Brouillard Inc., La Jolla

92270

Desert Hematology Oncology Medical Group, Rancho Mirage

92801

Pacific Cancer Medical Center, Anaheim

92868

Hematology/Oncology Group of Orange County, Orange

93309

Comprehensive Blood and Cancer Center, Bakersfield

93534

Antelope Valley Cancer Center, Lancaster

93710

California Oncology of the Central Valley, Fresno

94086

Camino Medical Group, Sunnyvale

94520

Bay Area Cancer Research Group, Concord

95008

Southbay Oncology Hematology Partners, Campbell

98104

Swedish Cancer Institute, Seattle

98503

Western Washington Oncology, Lacey

04074

Maine Center for Cancer Medicine - Blood Disorders, Scarborough

08003

Center for Cancer & Hematology Disease, Cherry Hill

08816

Central Jersey Oncology Center, East Brunswick

07601

Hackensack University Medical Center, Hackensack

08043

CINJ at Cooper University Hospital, Voorhees Township

02920

Hematology & Oncology Associates of RI, Cranston

02908

Roger Williams Hospital Medical Center, Providence

75390-9179

UT Southwestern Medical Center, Dallas

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY